A national standard that has been in force for nearly two decades is undergoing a systematic overhaul. In June 2025, the revision plan for the absorption method of antibacterial textile evaluation was issued, and a review meeting held in Zhejiang has pushed this core standard to the brink of implementation. For the textile supply chain, this is not just a text update but a potential reshaping of compliance thresholds and market order for antibacterial products.
Standard revision enters final stage
The GB/T 20944 series consists of three parts: the agar plate diffusion method (2007 version), the absorption method (2007 version), and the shaking method (2008 version). The revision of the shaking method was initiated in June 2024 (plan number 20241952-T-608) and has now been completed, pending approval. The absorption method revision was assigned in June 2025 (plan number 20251603-T-608), and this review meeting marks substantial progress. Both standards will fully replace their old versions upon release, establishing a new testing benchmark.
Notably, the drafting units cover testing institutions, research institutes, brand companies, and new material enterprises. This cross-sector participation reflects the complexity of the revision—balancing laboratory operability with market demands for functional claims. For buyers, this means future acceptance criteria for antibacterial fabrics will be more diverse and stringent.
Two decades of industrial change drive technical upgrade
When the original standards were released, antibacterial textiles were mainly limited to underwear and socks. Today, from sportswear to home textiles, from medical textiles to outdoor gear, antibacterial functionality has become a standard feature in mid-to-high-end products. Meanwhile, new antibacterial materials like nano-silver, chitosan, and photocatalytic agents have emerged, and testing techniques have evolved from simple inhibition zone measurements to more precise quantitative analyses. The old methods often yield biased or poorly reproducible results when applied to these new materials, undermining comparability across laboratories.
This technical gap has led to market confusion. Some companies exploit loopholes in testing methods to exaggerate antibacterial rates, while consumers struggle to verify claims under the existing framework. The revised standard will adopt more realistic test conditions, such as stricter bacterial strains and inoculation methods closer to actual contact, helping to curb false advertising and reward companies that invest in genuine technology.
Transmission effects across the supply chain
The revision will first impact testing costs. New methods may require higher laboratory specifications and longer incubation periods, likely increasing third-party testing fees for antibacterial fabrics. For exporters, if the new national standard aligns better with international standards like ISO 20743, it could reduce the burden of duplicate testing—a potential benefit.
For manufacturers, the revised standard will force process optimization. Past practices of relying on high concentrations of antibacterial agents to meet requirements may no longer work under new methods. Companies will need to focus on dispersion, wash durability, and safety of antibacterial agents. This effectively pushes the industry from "additive antibacterial" toward "structural antibacterial," which long-term enhances the international competitiveness of Chinese antibacterial textiles.
From a market perspective, standard revisions often trigger a shakeout. Small brands lacking technical reserves and relying solely on concept marketing may be eliminated, while leading companies with R&D capabilities will gain greater pricing power. Buyers should prioritize suppliers that proactively conduct internal testing against the new standard, as such companies typically have stronger quality systems.